Related Experiment Video
Updated: May 29, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Ageing skin: oestrogen receptor β agonists offer an approach to change the outcome
Richard L Jackson1, Jeffrey S Greiwe, Richard J Schwen
1Ausio Pharmaceuticals, LLC, Cincinnati, OH 45212, USA. richard@ausiopharma.com
Abstract:
Oestrogen (17β estradiol) and the dietary antioxidants resveratrol, genistein and S-equol, an isoflavone produced from the gut biotransformation of soy daidzein, are effective agents to reduce ageing in skin. It is widely held that these antioxidants scavenge free radicals to prevent skin damage. However, the evidence to date suggests that the primary mechanism of action of these antioxidants is to activate oestrogen receptor β (ERβ), which in turn enhances the expression of antioxidant enzymes and inhibits the expression of snail, a transcription factor that regulates keratinocyte cell proliferation and migration. Based on their selectivity, ERβ agents provide a treatment option for ageing skin without the potential safety issues associated with oestrogen therapy.
Related Concept Videos
Renewal of Skin Epidermal Stem Cells
The Effect of Aging on Tissues
Acne Infection
Menopause
Oogenesis
Clinical Applications of Epidermal Stem Cells
